UBS Starts CVS Caremark (CVS) at Buy, $34 Target
More News related to CVS
- Highlights From CVS's Q4 Conference Call: Issues Mixed Guidance for Q1 and FY10
- Barron's Believes that CVS (CVS), Henry Schein (HSIC), Western Union (WU), and Fiserv (FISV) are Good Plays in a Challenging Economy (PETM, MHS)
- CVS (CVS) Guides Q1, FY10 on It's Call
- CVS Caremark (CVS) Earnings Grow In Q4, Sales Fall Short
- CVS Caremark Reports Record Results in Fourth Quarter and Fiscal 2009
More News related to New Coverage
- Janney Montgomery Scott Initiates Coverage on Papa John's International (PZZA) with a Neutral
- Feltl & Co. Initiates Coverage on ActivIdentity (ACTI) with a Buy
- Oscar Gruss Initiates Coverage Airgas (ARG) with a Buy
- Sidoti & Co Initiates Coverage on Solutia (SOA) with a Buy
- RBC Capital Initiates Coverage on Questar (STR) with a Sector Perform
UBS initiates coverage on CVS Caremark (NYSE: CVS) with a Buy rating and a $34 price target.
Despite the new Buy rating, shares of CVS are down about a half percent, moving lower with the broader markets.
UBS also started 8 stocks in the Healthcare sector this morning.
CVS Caremark Corporation, a pharmacy services company, provides prescriptions and related healthcare services in the United States.
Related Categories
New CoverageStocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
